Dr. William Julius Shergy, MD

Dr. Shergy practices at Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL.

Dr. Shergy's NPI, 1073531307, was assigned on July 17, 2006. Dr. Shergy graduated from Hahnemann University College of Medicine in 1982. Dr. Shergy holds Alabama license 13812.

Dr. Shergy's primary practice is Huntsville Hospital, at 101 Sivley Rd, Huntsville, AL 35801 in Madison County. The practice phone is (256) 265-1000.

Dr. Shergy's primary practice is Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL. Dr. Shergy is also affiliated with Marshall Medical Center South. The medical group on file is Rheumatology Associates of North Alabama. Dmand AI also links Dr. Shergy to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shergy practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Shergy's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Shergy is licensed in Alabama.

CMS data shows 168,570 Medicare services from Dr. Shergy across 40 procedure codes in 2024, for 935 Medicare patients. Medicare paid $2,239,578 for them. Every service was in an office.

CMS counts 935 Medicare patients who saw Dr. Shergy in 2024. The largest group is 65 to 74, with 387 patients. 75% of them have arthritis, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shergy's median patient age at 70, with 76% women.

In 2024, Dr. Shergy wrote 7,367 Medicare Part D claims for 894 patients. 92% of them were for generic drugs. CMS names the drug for 7,139 of them, across 52 drugs with 11 or more claims each, at $3,668,546 in total drug cost. In 2023, CMS named 6,710 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Shergy for performance year 2024, reported through an alternative payment model (APM). Dr. Shergy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Shergy, published from 2011 to 2021. 2017 was the busiest year, with 2. The most frequent topics are Arthritis, Rheumatoid, Double-Blind Method and Antirheumatic Agents. Dr. Shergy has published most often in Ann Rheum Dis. Dr. Shergy's most frequent co-authors are Jeffrey R. Curtis, MD, Maria I. Danila and Kenneth G. Saag.

Dmand AI links Dr. Shergy to 6 clinical trials, 3 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Fibromyalgia and Muscular Diseases. R-Pharm International, LLC sponsors the most, 3. Open Payments lists research payments to Dr. Shergy that name 2 trials.

CMS Open Payments shows 1,929 general payments to Dr. Shergy from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Janssen Pharmaceuticals, Inc paid the most, $101,797. It also lists 18 research payments totaling $19,980 in 2016, naming 2 clinical trials.

Dr. Shergy graduated from Hahnemann University College of Medicine in 1982.